corticosterone has been researched along with Parkinson Disease in 12 studies
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary motor symptoms of Parkinson's disease (PD) result from the degeneration of dopamine-producing neurons of the substantia nigra pars compacta (SNc), and often, the loss is asymmetrical, resulting in unilateral tremor presentation." | 1.62 | Characterizing the protracted neurobiological and neuroanatomical effects of paraquat in a murine model of Parkinson's disease. ( Ayoub, K; Beauchamp, S; Derksen, A; Dwyer, Z; Farmer, K; Fortin, T; Hayley, S; Rudyk, C; Shail, P; Torres, C; Ventura, K, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Wu, J | 1 |
| Yang, X | 2 |
| Cai, P | 1 |
| Liu, Q | 1 |
| Wang, KDG | 1 |
| Kong, L | 1 |
| Wang, X | 1 |
| Burtscher, J | 1 |
| Copin, JC | 1 |
| Rodrigues, J | 1 |
| Kumar, ST | 1 |
| Chiki, A | 1 |
| Guillot de Suduiraut, I | 1 |
| Sandi, C | 1 |
| Lashuel, HA | 1 |
| Dwyer, Z | 1 |
| Rudyk, C | 1 |
| Farmer, K | 1 |
| Beauchamp, S | 1 |
| Shail, P | 1 |
| Derksen, A | 1 |
| Fortin, T | 1 |
| Ventura, K | 1 |
| Torres, C | 1 |
| Ayoub, K | 1 |
| Hayley, S | 1 |
| Hao, Y | 1 |
| Shabanpoor, A | 1 |
| Metz, GA | 1 |
| Agnihotri, SK | 1 |
| Sun, L | 1 |
| Yee, BK | 1 |
| Shen, R | 1 |
| Akundi, RS | 1 |
| Zhi, L | 1 |
| Duncan, MJ | 1 |
| Cass, WA | 1 |
| Büeler, H | 1 |
| Sugama, S | 1 |
| Kakinuma, Y | 1 |
| Wu, Q | 1 |
| Zhang, Y | 1 |
| Zhang, L | 1 |
| Feng, L | 1 |
| Engler, H | 1 |
| Doenlen, R | 1 |
| Riether, C | 1 |
| Engler, A | 1 |
| Niemi, MB | 1 |
| Besedovsky, HO | 1 |
| del Rey, A | 1 |
| Pacheco-López, G | 1 |
| Feldon, J | 1 |
| Schedlowski, M | 1 |
| Pålhagen, S | 1 |
| Qi, H | 1 |
| Mårtensson, B | 1 |
| Wålinder, J | 1 |
| Granérus, AK | 1 |
| Svenningsson, P | 1 |
| Gorton, LM | 1 |
| Vuckovic, MG | 1 |
| Vertelkina, N | 1 |
| Petzinger, GM | 1 |
| Jakowec, MW | 1 |
| Wood, RI | 1 |
| GILLHESPY, RO | 1 |
| RATCLIFFE, AH | 1 |
| Sawada, H | 1 |
| Ibi, M | 1 |
| Kihara, T | 1 |
| Urushitani, M | 1 |
| Akaike, A | 1 |
| Shimohama, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Mindfulness-based Cognitive Therapy on Psychological Distress in People With Parkinson's Disease[NCT05779137] | 124 participants (Anticipated) | Interventional | 2023-04-17 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 other studies available for corticosterone and Parkinson Disease
| Article | Year |
|---|---|
Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson's disease.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Mice; Mice, Inbred S | 2016 |
Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology.
Topics: alpha-Synuclein; Animals; Behavior, Animal; Brain; Corticosterone; Disease Models, Animal; Dopaminer | 2019 |
Characterizing the protracted neurobiological and neuroanatomical effects of paraquat in a murine model of Parkinson's disease.
Topics: Age Factors; Animals; Antigens, Surface; Brain; Caspase 1; Corticosterone; Disease Models, Animal; D | 2021 |
Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
Topics: Adrenalectomy; Animals; Corticosterone; Disease Models, Animal; Dopamine; Male; Membrane Proteins; M | 2017 |
PINK1 deficiency is associated with increased deficits of adult hippocampal neurogenesis and lowers the threshold for stress-induced depression in mice.
Topics: Animals; Anxiety; Anxiety Disorders; Behavior, Animal; Cell Differentiation; Cell Proliferation; Cor | 2019 |
Loss of dopaminergic neurons occurs in the ventral tegmental area and hypothalamus of rats following chronic stress: Possible pathogenetic loci for depression involved in Parkinson's disease.
Topics: Animals; Corticosterone; Depression; Dopaminergic Neurons; Hypothalamus; Male; Microglia; Nerve Dege | 2016 |
Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice.
Topics: alpha-Synuclein; Animals; Body Weight; Case-Control Studies; Chromatography, High Pressure Liquid; C | 2016 |
Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Cell Count; Corpus Striatum; Corticoste | 2009 |
Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression.
Topics: Aged; Analysis of Variance; Biogenic Monoamines; Brain-Derived Neurotrophic Factor; Corticosterone; | 2010 |
Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anxiety; Behavior, Animal; Brain; Corticoster | 2010 |
Treatment of Parkinsonism with a new compound (B.S.5930).
Topics: Corticosterone; Diphenhydramine; Parkinson Disease; Parkinsonian Disorders | 1955 |
Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death.
Topics: Animals; Cells, Cultured; Corticosterone; Dopamine; Estradiol; Estrogen Antagonists; Glutamic Acid; | 1998 |